Goldman Sachs Maintains Bullish Stance on Bristol-Myers (BMY) Following ASCO
Tweet Send to a Friend
Shares of Bristol-Myers Squibb Co. (NYSE: BMY) fractionally higher Monday following several positive data sets on its anti-PD1 BMS-936558 at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
